Skip navigation
FACT
Focus on Alternative and Complementary Therapies

Paediatric outpatients’ use of CM

Lorenc A1, Robinson N1, Blair M2, Mitchell K3, Gully N3, Fox P3
1Centre for Complementary Healthcare and Integrated Medicine, Faculty of Health & Human Sciences, Thames Valley University, Walpole House, 18–22 Bond Street, Ealing, London W5 5AA, UK
2River Island Paediatric and Child Health Academic Centre, Imperial College, Northwick Park Hospital Campus, Watford Road, Harrow, Middlesex HA1 3UJ, UK
3Psychology Department, Thames Valley University, St Mary’s Road, Ealing, London W5 5RF, UK

Objective

To determine the prevalence and determinants of CM use in a multi-ethnic paediatric outpatient population.

Materials and methods

A parent-completed questionnaire survey of 201 paediatric outpatients attending general and sub-specialist clinics was conducted at a North West London hospital. The questionnaire investigated the use of CM, including cost, attendance, sources of CM, perceived efficacy, reasons for use and communication with doctors. Standardised questionnaires explored beliefs in medicines and health locus of control. Data was analysed using cross tabulations, chi-squared, t-test and multiple logistic regression. COREC ethical approval was obtained.

Results

Results showed that 37% of parents used CM for their children. Use was correlated with parental CM use (P < 0.001), income (P = 0.05) and education (P = 0.01). Parental CM use and child’s health status were significant predictors of CM use (P < 0.001 and P < 0.05). The main reason for using CM was word of mouth (65%) and the main source of information was friends and family (51%). Homoeopathy and herbal medicine were the most popular treatments. Sixty-one per cent of CM was bought OTC and 54% of CM use was not reported to the children’s doctors. Parents who used CM for their children had significantly stronger beliefs in the overuse of conventional medicine (P = 0.031).

Conclusion

These results suggest that the prevalence of CM use for children in the UK is much higher than previously estimated. This has safety implications and indicates the need for greater awareness of CM amongst child health-care and primary care professionals.

Top | Next: What a difference a trial makes!»
© Pharmaceutical Press 2008
Accessibility | Terms and Conditions